Yayın:
Systematic review of survey/questionnaire-based drug utilization studies in Turkiye

dc.contributor.authorGültekin, Onur
dc.contributor.authorHaspolat, Nazim
dc.contributor.authorÇiçek, Bahar
dc.contributor.authorHavyarimana, Dieudonné
dc.contributor.authorAkıcı, Ahmet
dc.contributor.authorAydin, Volkan
dc.contributor.buuauthorHASPOLAT, NAZIM
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentTıbbi Farmakoloji Ana Bilim Dalı
dc.contributor.scopusid59463801600
dc.date.accessioned2025-05-12T22:29:10Z
dc.date.issued2024-01-01
dc.description.abstractOBJECTIVE: Drug utilization studies (DUS), providing insights into various aspects of pharmacoepidemiology from prescrib-ing to medication use, can be conducted through real-world data from health records and survey-based data. In this study, we aimed to describe survey/questionnaire-based DUS conducted in Turkiye. METHODS: We searched online databases for the most frequently used keywords in DUS from January 1993 till May 2023 and identified 180 survey-based DUS conducted in Turkiye. We described DUS by their populations, sociodemographic characteristics, timeframe, setting and provinces, data collection method, medication categories, and article-specific variables were evaluated. RESULTS: We identified that 68.3% of the DUS were in English and 91.7% were indexed in Web of Science (median 1 [interquartile range: 1–2] citation). We found that 21.7% of the articles (n=39) had pharmacology affiliation. Adults are the target population in 37.8% of the studies and age and gender were not reported in 27.2% and 16.7%, respectively. The response rate was not stated in 55.0%. We determined that 48.3% of the studies were focused on a single medication/ medication group. The mean time from data collection to publication was 2.5±1.9 years, and the highest number of articles (10.6%) were published in 2021. CONCLUSION: Our systematic review shows that the majority of DUS were listed in well-known international indices, suggesting that our local studies invoke global interest and hold a valuable position in health research. Nevertheless, lack of reporting of methodological characteristics in substantial part of the studies can be considered an important room for improvement of DUS.
dc.identifier.doi10.14744/NCI.2024.60252
dc.identifier.endpage533
dc.identifier.issn2148-4902
dc.identifier.issue6
dc.identifier.scopus2-s2.0-85211361194
dc.identifier.startpage525
dc.identifier.urihttps://hdl.handle.net/11452/51322
dc.identifier.volume11
dc.indexed.scopusScopus
dc.language.isoen
dc.publisherKare Publishing
dc.relation.journalNorthern Clinics of Istanbul
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectSystematic review
dc.subjectSurvey
dc.subjectQuestionnaire
dc.subjectPharmacoepidemiology
dc.subjectDrug utilization studies
dc.subject.scopusSelf Report and Drug Therapy in Pharmacoepidemiology
dc.titleSystematic review of survey/questionnaire-based drug utilization studies in Turkiye
dc.typeArticle
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/Tıbbi Farmakoloji Ana Bilim Dalı
local.indexed.atScopus
relation.isAuthorOfPublication4803ed47-fb0d-4e80-a9a1-042779307dc2
relation.isAuthorOfPublication.latestForDiscovery4803ed47-fb0d-4e80-a9a1-042779307dc2

Dosyalar